REGENXBIO Inc. (RGNX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.39 |
| Open | 14.58 |
| Bid | 14.27 x 200 |
| Ask | 14.35 x 200 |
| Day's range | 14.16 - 14.77 |
| 52-week range | 10.49 - 28.80 |
| Volume | |
| Avg. volume | 539,006 |
| Market cap | 705.838M |
| Beta (5Y monthly) | 1.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.87 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 38.92 |
PR NewswireREGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights
REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, August 1, 2024, at 4:30 p.m. ET to discuss its financial results for the second quarter ended June 30, 2024, and recent operational highlights.
ZacksRegenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
Regenxbio (RGNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ZacksHere's Why Sarepta (SRPT) Stock Price Surged 57% YTD
Sarepta (SRPT) surges on the commercial potential of its Elevidys, the first FDA-approved gene therapy for Duchenne muscular dystrophy.
© 2024 Yahoo. All rights reserved.